netFormulary Berkshire West NHS NHS
Royal Berkshire NHS Foundation Trust
Berkshire Healthcare NHS Foundation Trust
Berkshire West Clinical Commissioning Group
 
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
Notes:
This formulary is used by multiple organisations. There may be some instances where an item is on the formulary for one organisation but not the others. To help distinguish between each organisation, text will be colour coded, i.e. information relating to the Royal Berkshire NHS Foundation Trust will be in blue and Berkshire Healthcare NHS Foundation Trust will be in purple. Please ensure you read all information detailed under a drug.   
 Details...
04.09.01  Expand sub section  Dopaminergic drugs used in Parkinsons disease
04.09.01  Expand sub section  Dopamine receptor agonists
Apomorphine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS Foundation Trust >> NON - Formulary Item - contact pharmacy for advice
 
Link  APC 045 Apo-go® for Parkinson’s Disease updated March 2017
   
Bromocriptine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS FOundation Trust >> Formulary Item tablets / capsules
 
   
Cabergoline
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS FOundation Trust >> Formulary Item tablets
 
   
Cabergoline (Cabaser®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS FOundation Trust >> Formulary Item see generic drug for details (brand may not be available - contact pharmacy for advise)
 
   
Pergolide
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS FOundation Trust >> Formulary Item tablets
 
   
Pramipexole
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Ordinary release tablets are significantly cheaper than modified release preparations. Modified release preparations confer no additional clinical benefits

Royal Berkshire NHS Foundation Trust >> Formulary Item MR tablets (for PD ONLY)
 
   
Ropinirole
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
Can be used in severe restless leg syndrome, see APC policy statement and treatment pathway

Royal Berkshire NHS FOundation Trust >> Formulary Item tablets / MR tablets
 
Link  APC 079: Ropinirole for restless leg syndrome
   
Rotigotine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber
Royal Berkshire NHS FOundation Trust >> Formulary Item patches

 
   
04.09.01  Expand sub section  Levodopa
04.09.01  Expand sub section  Monoamine-oxidase-B inhibitors
04.09.01  Expand sub section  Catachol-O-methyltransferase inhibitors to top
04.09.01  Expand sub section  Amantadine
 ....
 Non Formulary Items
Lisuride

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Amber
Royal Berkshire NHS Foundation Trust >> NON - Formulary Item - contact pharmacy for advice
 
Pergolide  (Celance®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Amber
Royal Berkshire NHS Foundation Trust >> Formulary Item see generic drug for details (brand may not be available - contact pharmacy for advise)
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Medicines that should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the primary care provider that the prescribing responsibility has been transferred. Where applicable, shared care protocols will be agreed and must be adhered to. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s)(DTC) and approved by Berkshire West APC.   

Brown

Drugs that have been reviewed and not recommended for prescribing. These drugs are not considered a cost effective use of scarce NHS resources. There may be individual patient specific or clinical reasons why a drug deemed low priority may be suitable for a particular patient. This is for the GP to condsider, weighing up the reasons against his/her allocated CCG budget. Where the decision is made to prescribe a low priority drug, detailed documentation must be included within the patients' notes for audit purposes. *Please note that low priority drug requests are unsuitable for the Case Review Committee and therefore should not be sent to this committee.   

Green

Medicines suitable for routine use and can be prescribed within primary care within their licensed indication in accordance with the BNF or other recognised national formulary. Primary care prescribers take full responsibility for prescribing  

Red

Medicines which should be prescribed by specialists only  

netFormulary